Capricor Therapeutics Inc (NASDAQ:CAPR)
| 2.95 Delayed Data As of 3:59pm ET |  -0.02 / -0.67%Today’s Change | 2.68 Today|||52-Week Range 8.22 | -23.58% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 5.6M | 4.6M | 6.9M | 4.5M | |
| Short Term Investment Cash | -5.4M | -1.0M | 2.3M | -2.3M | ||
| Cash & Short Term Investments | 13.6M | 17.5M | 14.9M | 7.5M | ||
| Receivables | Receivables | 211.9K | 223.3K | 344.6K | 204.9K | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 210.6K | 342.9K | 501.2K | 724.2K | |
| Current Assets | 14.0M | 18.1M | 15.7M | 8.5M | ||
| Total Assets | Property, Plant and Equipment - Gross | 492.3K | 686.0K | 713.7K | 1.0M | |
| Depreciation | -173.7K | -250.7K | -341.7K | -456.0K | ||
| Intangible Assets | 1.7M | 142.3K | 93.0K | 49.8K | ||
| Other Assets | 1.8M | 203.7K | 189.0K | 201.6K | ||
| Total Assets | 16.1M | 18.7M | 16.3M | 9.2M | ||
| Liabilities | Accounts Payable | 2.5M | 3.0M | 1.5M | 1.3M | |
| Accrued Expenses | 352.3K | -- | -- | -- | ||
| Other Current Liabilities | 4.0M | 1.9M | 174.4K | 0.00 | ||
| Other Liabilities | 6.5M | 4.9M | 1.7M | 1.3M | ||
| Total Liabilities | Long Term Debt | 9.2M | 17.0M | 3.4M | 0.00 | |
| Other Liabilities | 505.4K | 849.5K | 0.00 | 0.00 | ||
| Total Liabilities | 17.1M | 22.8M | 5.0M | 1.3M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | -1.0M | -4.0M | 11.2M | 4.6M | ||
| Total Shareholder Equity | -1.0M | -4.0M | 11.2M | 4.6M | ||
| Share Information | Common Shares Outstanding | 1.6M | 2.1M | 2.6M | 3.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
